Anulex
closedAnulex Technologies develops technologies and surgical techniques to improve the treatment of herniated discs.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
| investor investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
$18.3m | Series E | ||
| Total Funding | 000k | ||
Anulex Technologies was a medical device company that developed and commercialized products for soft tissue repair, with a primary focus on treatments for the spine. The company's main product was the Xclose Tissue Repair System, a medical device designed to close the hole in the anulus fibrosus (the outer ring of the intervertebral disc) after a discectomy, a surgical procedure to remove a herniated disc.
The primary clients for Anulex's products were surgeons, specifically those performing spinal surgeries. The company operated in the medical device market, a sector that is characterized by long product development cycles, stringent regulatory requirements, and the need for extensive clinical data to support product adoption.
Anulex's business model was based on the development and sale of its proprietary medical devices to hospitals and surgical centers. The company's revenue was generated from the sales of the Xclose system. The company was privately held and raised capital from investors to fund its research and development, clinical trials, and commercialization efforts.
Keywords: medical devices, soft tissue repair, spinal surgery, anulus fibrosus, discectomy, Xclose, herniated disc, surgical procedure, medical technology, tissue repair